News
-
-
PRESS RELEASE
M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
M1 Kliniken AG reports strong EBIT growth of 11% and achieves earnings per share of EUR 0.86 in the first nine months of 2025, with key financials showing positive trends in revenue and profitability -
-
PRESS RELEASE
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
HAEMATO AG, 100% subsidiary of M1 Kliniken AG, sells HAEMATO Pharm GmbH to PHOENIX group. Transaction details undisclosed. M1 Kliniken AG aims for global leadership in medical aesthetics -
-
-
-
PRESS RELEASE
Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH has published a research update on M1 Kliniken AG, reaffirming a buy rating with a target price of EUR 28. Recent financial performance and strategic outlook support the positive assessment -
-